Please read the poster presentation guideline carefully. Also, please be aware there are no local commercial print facilities, so please print your poster prior to coming to Tsuruoka.

Click here to download the floor map of exhibition area

Marica East


P1 Metabolic profiling of Wolfram syndrome 1 gene deficient mouse. Rando Porosk (Institute of Biomedicine and Translational Medicine).

P2 Metabolic profiling of T2DM model mouse response to glucose challenge identifies abnormal metabolic changes in the liver and muscle. Toshiya Kokaji (Department of Computational Biology, Graduate School of Frontier Sciences, University of Tokyo).

P3 Metabolic effects of glucocorticoid block in diabetes and non-alcoholic fatty liver disease. David George Watson (University of Strathclyde).

P4 Metabolomic profiling reveals novel biomarkers of alcohol-induced hypertension in community-dwelling men: Tsuruoka metabolomic study. Sei Harada (Keio University School of Medicine).

P5 Metabolomics to assess altered myocardial metabolism in type 1 (NOD) and type 2 (ob/ob) diabetic mouse models underlying diabetic cardiomyopathy. Xinzhu Wang (Department of Biochemistry, University of Cambridge; Human Nutrition Research, MRC).

P6 Mass Spectrometry Metabolomic Approaches Lead to a New Paradigm for Fabry Disease Patient Investigation. Christiane Auray-Blais (Universite de Sherbrooke).

P7 Discovery of Galabiosylceramide-Related Fabry Disease Urinary Biomarkers Using a Mass Spectrometry-Based Metabolomic Approach. Michel Boutin (Universite de Sherbrooke).

P9 Multiple Metabolic Abnormalities in a Cohort of Idiopathic Parkinson's Disease Patients: Discovery via Urinary Metabolomics. Hemi Luan (Hong Kong Baptist University).

P10 A CE-MS based metabolome analysis of mice whole brain in light/dark phase. Atsushi Sato (Lion Corporation).

P11 Global metabolomics reveals urinary biomarkers of alzheimers disease in the crnd8 transgenic mouse model. Zhi Tang (Hong Kong Baptist University).

P12 Blood metabolic patterns associate with the severity of traumatic brain injury and predict patient outcomes. Tuulia Hyotylainen (Steno Diabetes Center, Gentofte, Denmark).

P13 Wax ester profiling of Euglena gracilis by gas chromatography-mass spectrometry: toward understanding of anoxia wax ester fermentation. Takeshi Furuhashi (RIKEN CSRS).

P14 Modulation by temperature of purified phosphoenolpyruvate carboxylase from Amaranthus hypochondriacus L. (a C4 plant): protection by PEG-6000. Bhaskarrao Chinthapalli (Arba Minch University).

P15 A facile means for the identification of indolic compounds. Peng Yu (University of Minnesota).

P16 Chemical regulation of photorespiratory hydrogen peroxide-dependent cell death. Pavel Kerchev (VIB Department of Plant Systems Biology).

P17 Changes in membrane glycerolipids under heat stress in Arabidopsis leaf. Yasuhiro Higashi (RIKEN CSRS).

P18 Non-targeted metabolite profiling of different cultivars of rice seeds (Oryza sativa L.) by GC-TOF-MS and UPLC-Q-TOF-MS. Ga Ryun Kim (Konkuk University).

P19 Metabolome analysis of rosaceous fruits. Akira Oikawa (Yamagata University).

P20 Lipidome analysis of glucuronosyldiacylglycerol-deficient mutants of Arabidopsis. Yozo Okazaki (RIKEN).

P21 Long-chain base desaturases modulate metabolic flow of complex glycosphingolipids in rice. Toshiki Ishikawa (Saitama University).

P22 Characterization of flavor in apple Fuji with a focus on pre-harvest conditions. Fukuyo Tanaka (NARO-Agricultural Research Center).

P23 Analysis of the metabolite profiles of Arabidopsis thaliana expressing the enzymes from quinolizidine alkaloids producing plant: Lupinus angustifolius. Hajime Tomatsu (Chiba University).

P24 Tryptophan metabolism in mice infected with Plasmodium berghei ANKA: 1H NMR-based metabolomic investigation. Rustam Singh (Tata Institute of Fundamental Research).

P25 Transketolase in Leishmania mexicana: regulation of subcellular localisation and metabolic roles. Julie Kovarova (University of Glasgow).

P26 Metabolome analysis for identifying biomarkers of Chronic Fatigue Syndrome. Emi Yamano (Osaka City University Graduate of School of Medicine).

P27 In vivo metabolite visualization using standardized imaging mass spectrometry. Shuichi Shimma (National Cancer Center Research Institute).

P28 A novel High Resolution Human Metabolite MS/MS Spectral Library enables Rapid and Accurate Metabolite Identification of Human Biofluids . Zhendong Li (University of Alberta, Edmonton, CANADA).

P29 A novel atmospheric pressure GC Source coupled to high resolution TOF-MS Analysis improves quantitative and qualitative metabolic profiling studies. Christian Wachsmuth (University of Regensburg, Regensburg, Germany).

P30 In vivo exhaled breath analysis: an alternative approach to address lung disease diagnosis, chronobiology and drug monitoring. Pablo M-L Sinues (ETH Zurich).

P31 Evaluating the integration of CE, ESI and mass pectrometry for the quantitative analysis of amino acids in the cationic metabolome. John C. Hudson (University of Regina, Regina, SK, Canada).

P32 Multi-segment Injection-Capillary Electrophoresis-Mass Spectrometry: Multiplexed Separations for Biomarker Discovery in Metabolomics. Philip Britz-McKibbin (McMaster University).

P33 Development of rapid whole cell metabolomic screening for volatile compounds. Ameerah Mohammed Bokhari (KAUST).

P35 Metabolic phenotype of the healthy rodent model using in-vial extraction of dried serum, urine, and cerebrospinal fluid spots. Yaoyao Wang (King's College London).

P36 Using PCI-IS for targeted metabolomics analysis of amino acids and its application on breast cancer research. Hsiao-Wei Liao (National Taiwan University).

P37 A comparative metabolomic method for time series investigation of fatty acid expressions. Guan-Yuan Chen (National Taiwan University).

P38 Higher resolution LC-MS and MS-MS analysis of lipid extracts using benchtop Orbitrap-based mass spectrometers and LipidSearch software. David A Peake (Thermo Fisher Scientific).

P39 Novel Metabolic Assay for Pre-Analytical Quality Control of Human Plasma Samples. Beate Kamlage (meatnomics GmbH).

P40 Strategic Utilization of Gas Chromatography with both Nominal and High Resolution Time-of-Flight Mass Spectrometers for Metabolomic Studies. Jeffrey Patrick (LECO Corporation).

P41 Characterization of metabolites from M. truncatula using gas chromatography mass spectrometry for characterization of knowns and unknowns. David Alonso (LECO Corporation).

P42 Saponarin isolated from barley sprouts attenuates LPS-induced inflammation by suppressing NF-kB activation in RAW 264.7 macrophages. Woo Duck Seo (Rural Development Administration ).

P43 Metabonomic responses of MnIO-NPs as potential dual-modal contrast agents. Jianghua Feng (Xiamen University).

P44 Determination of lipoic acid and its metabolites in human urine by mass spectrometry. Chia Ju Tsai (Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University).

P45 Determination of androgenic steroids and metabolites in urine by full-capillary sample injection combined with a sweeping CE method. Chun-Chi Wang (Kaohsiung Medical University).

P46 Determination of Saikosaponins and metabolites by chemometric experimental design and cyclodextrin modified micellar electrokinetic chromatography. Kuan-Ling Chen (Kaohsiung Medical University).

P47 Application of experimental design for the determination of ultraviolet absorbents and their metabolites by capillary electrophoresis. Wen-Yao Hsiao (Kaohsiung Medical University).

P48 Gas chromatography mass spectrometry-based serum metabolomics for diagnosis and assessment of ulcerative colitis. Masaru Yoshida (Kobe University).

P49 Metabolomic investigations of the effect of simvastatin on lipid synthesis by using UPLC coupled with TOF mass spectrometry. Yibao Jin (Shenzhen Institute for Drug Control).

P50 Metabolomics application for searching adenosine a1 receptor ligands from indonesian medicinal plants. Nancy Dewi Yuliana (Bogor Agricultural University).

P51 Ftir metabolomics to study sorghum phytochemicals changes and its antiproliferative activity against hct 116 during analogue rice production. Slamet Budijanto (Bogor Agricultural University).

P52 Metabolic imbalances due to oxidative stress in endometriosis: 1H NMR based metabonomics. Saikat K Jana (Indian Institute of Technology, Kharagpur 721302, India).

P53 Integration of metabolomics with pharmacokinetic drug interaction: CYP3A-mediated metabomarkers in male and female. Joo-Youn Cho (Seoul National University).

P55 Application of metabolomics for quality evaluation of licorice (Glycyrrhiza uralensis Fisher). Kazuo Harada (Osaka University).

P56 Noninvasive and real-time monitoring of ketamine pharmacokinetics by mouse breath analysis using secondary electrospray ionization mass spectrometry. Xue Li (Jinan University).

P57 Rapid identification and comparative analysis of the chemical constituents and metabolites of Antrodia cinnamomea fruiting body extracts by UPLC-MS. Hsin Jsn Yao (Industrial Technology Research Institute).

P58 Screening of kukoamine allies in Lycii Cortex using a multiple ion monitoring-dependent enhanced MS/MS acquisition method on Q-TRAP MS. Yuan-Yuan Li (City University of Hong Kong).

P59 Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis. Mohamed Nawfal Triba (Universite Paris 13, Sorbonne Paris Cite).

P60 Metabolome analysis of maternal hair provides stable biomarkers for Gestational Diabetes Mellitus. Jamie Violet de Seymour (University of Auckland).

P61 Smoking of mothers causes mirrored changes in the endogenous metabolome of mothers at 34th of gestation and in unborn children. Ulrike Elisabeth Rolle-Kampczyk (Helmholtz Centre for Environmental Research Leipzig, Department of Metabolomics).

P62 Metabolomic profiling of mice serum associated with trans-trans 2, 4-decadienal, a component of cooking oil fumes induced lung lesions by LC-MS. Chao Yu Chen (Fu Jen Catholic University).

P63 Metabolomics approach in human health risk assessment of pesticides. RATNASEKHAR CH (Council of Scientific and Industrial Research-Indian Institute of Toxicology Research).

P64 Metabolomics approach to understand the resource partitioning in Chlorella during growth for enhanced biofuel production. Sanjay Swarup (Department of Biological Sciences & NUS Environmental Research Institute (NERI), National University of Singapore, Singapore Centre for Environmental Life Sciences Engineering (SCELSE)).

P65 MS-based lipidomics to explore the naphthalene toxicity in a tolerant mouse model. Si-Han Hong (National Taiwan University ).

P66 Lipidomics to study the biological effects of radiation exposure on two human lymphoblast cell lines. Yue-Ruei Li (Institute of Environmental Health).

P67 NMR-based Metabolomics to Determine the Acute Inhalation Effect of Nano- and Fine-Sized ZnO Particles in Rat Lung. Sheng-Han Lee (National Taiwan University).

P68 Intra-colonial distinction of cellular membrane accommodation to copper-induced oxidative stress in a pocilloporid coral Seriatopora caliendrum. Chuan-Ho Tang (National Museum of Marine Biology and Aquarium).

P69 Long-term exposure to bisphenol-A affacts steroid hormone profile in mother and baby pairs based on envorinmental metabolomics. Jeongae Lee (Korea Institute of Science and Technology).

P70 Identification of IDH3 as a novel target of tributyltin cytotoxicity by a metabolomic approach. Shigeru Yamada (National Institute of Health Sciences).

P71 Genetic and metabolomic dissection of the ergothioneine biosynthetic pathway in the fission yeast, S. pombe. Tomas Pluskal (Okinawa Institute of Science and Technology (OIST)).

P72 Effect of arginine metabolic pathways on periodontopathic biofilms formation. Ei Hashino (Osaka University Graduate School of Dentistry).

P73 Metabolomics perspective of acid stress response within Saccharomyces cerevisiae. Riyanto Heru Nugroho (Osaka University).

P74 Metabolic and molecular dissection of bulk RNA degradation via autophagy in yeast. Hanghang Huang (Osaka University).

P75 Investigation of component changes in soy sauce resulted from microbial activities during fermentation using metabolome analysis. Risa Harada (Osaka University).

P76 Metabolic characterization of three cyanobacterial strains by molar-based metabolic profiling. Yudai Dempo (Osaka University).

P77 Adaptive mutations improve carbon flow and metabolic efficiency for fast growth of Escherichia coli on glycerol. Kian-Kai Cheng (Keio University & Universiti Teknologi Malaysia).

P78 Profiling of stress-induced polar lipids in Euglena gracilis. Takumi Ogawa (Osaka Prefecture University).

P79 Effect of quenching method on the metabolic fingerprint of lactobacillus paracasei . Kristina Bak Jaepelt (Department of Plant and Environmental Sciences, University of Copenhagen).

PLB1 Inositol-1,4,5-trisphosphate receptor regulates glycolysis and citric acid pathway as revealed by metabolomics approach. WENJUN XU (college of pharmacy, Seoul National University).

PLB2 Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Xing Jin (Seoul National University).

PLB3 Metabolomics approaches in diagnosis and physiopathology of amyotrophic lateral sclerosis. Christian R Andres (Universite Francois Rabelais Tours).

PLB4 Metabolomic analyses reveal that acupuncture ameliorates the menopause-caused metabolic alterations. Huiru Tang (Wuhan Inst Phys Math, CAS).

PLB5 Metabolomics exploration of the role of CYP2E1 on alcohol induced fatty live. Sufan Wang (Sun Yat-sen University).

PLB6 A metabolic signature of skn-1 knockdown C.elegans. Phan Chau Hong Duc (Seoul National University).

  • Agilent Technologies
  • Bruker Corporation
  • Human Metabolome Technologies
  • LECO Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation